Io­vance comes back with an­oth­er up­beat can­cer tri­al up­date as #AS­CO19 cur­tain rais­er

Io­vance, one of the new dar­lings of the can­cer set, pulled off the cur­tain rais­er at AS­CO with an up­date that of­fers an­oth­er en­cour­ag­ing snap­shot of progress and po­ten­tial for its I/O drugs. 

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.